secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cocrystal Pharma, Inc. (COCP)
CIK:        0001412486
Form:       8-K
Filed at:   2025-09-15T23:59:59+00:00
Accession:  0001493152-25-013495
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cocrystal Pharma closes $4.7M registered direct offering with warrant coverage
------------------------------------------------------------------------------

- Gross proceeds of ~$4.75M from sale of 2,764,710 shares at $1.70 each.
- Warrants issued to purchase 5,529,420 shares at $1.50, potential additional $8.3M.
- Net proceeds for working capital and antiviral drug development.
- H.C. Wainwright acted as placement agent; warrants expire 24 months after resale registration effective.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1412486/000149315225013495/0001493152-25-013495-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1412486/000149315225013495/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-013495

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer